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Summary 
• Bipolar disorder, previously known as manic depression, is a common, lifelong, 
mental health condition characterised by recurring episodes of depression and 
mania. It is associated with significant impairment.
• Before APMS 2014, bipolar disorder had not been assessed in the UK general 
population. The World Mental Health Survey initiative incorporated screening 
for bipolar disorder, identifying a rate of 2.4% across 11 other countries.
• The 15-item Mood Disorder Questionnaire was added to the 2014 survey. 
A positive screen required endorsement of at least 7 lifetime manic/hypomanic 
symptoms, as well as several co-occurring symptoms, together with moderate 
or serious functional impairment. A positive screen indicated the likely presence 
of bipolar disorder and that fuller assessment would be warranted.
• Overall, 2.0% of the population screened positive for bipolar disorder. 
Rates were similar in men and women.
• Positive screening for bipolar disorder was more common in younger age-groups. 
3.4% of 16–24 year olds screened positive compared with 0.4% of those aged 
65–74. None of the participants aged 75 and over screened positive for bipolar 
disorder. It did not vary by region or ethnic group.
• Rates of positive screening for bipolar disorder were higher in non-employed 
people, in those receiving particular benefits, and in people living alone.
• Most people screening positive for bipolar disorder were not in receipt of 
psychotropic medication or psychological therapy at the time of the interview. 
Furthermore, one in eight had unsuccessfully requested a particular mental 
health treatment in the past 12 months.
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9.1 Introduction
Bipolar disorder, previously known as manic depression, is a common, lifelong, 
mental health condition. It is characterised by recurring episodes of depression 
(feelings of low mood and lethargy) and of mania (feelings of elation and 
overactivity) or hypomania (a milder form of mania) (RCPsych 2016). While at 
one level it is considered to lie on a spectrum, several subtypes can be identified, 
diagnoses of which are based on the frequency and pattern of episodes of (hypo)
mania and depression. Worldwide prevalence rates of bipolar disorder are estimated 
to be between 1.0% and 5.0% (Bebbington and Ramana 1995). These figures 
vary depending on the part of the bipolar spectrum researchers assess and the 
instruments used. The World Mental Health Surveys identified a rate of 2.4% across 
11 countries (Akiskal et al. 2000; Merikangas et al. 2011), and in the National 
Comorbidity Survey Replication, a US nationally representative study, prevalence 
rates for bipolar spectrum disorders were found to be 4.4% (Merikangas et al. 
2007). Prevalence rates have been found to be comparable in men and women, 
with an inverse relationship with age (Merikangas et al. 2011; Pini et al. 2005). 
At present, there is a lack of epidemiological data on the prevalence of bipolar 
disorder in the UK (Gupta and Guest 2002). One of the reasons that bipolar 
disorder has not been measured previously on APMS is that it requires information 
about lifetime symptoms, while APMS tends to focus on more recent time frames. 
This chapter, newly introduced in APMS 2014, therefore provides crucial data 
on the prevalence and socio-demographic profile of bipolar disorders in England. 
The World Health Organisation (WHO) identified bipolar disorder as the 6th 
leading cause of disability in the world (Murray and Lopez 1996). It leads to 
significant psychosocial impairment, such as fewer employment prospects and 
lower annual income (Coryell et al. 1993; Judd et al. 2005; Marwaha et al. 2013), 
as well as placing a great burden on health care services (Pini et al. 2005). The 
annual economic costs for bipolar disorder in England were estimated, in 2007, 
to be £5.2 billion, two thirds of which was attributable to loss of employment. 
This estimation is projected to rise to £8.21 billion by 2026 (McCrone et al. 2008). 
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Bipolar disorder is comorbid with a number of other disorders such as 
substance misuse, anxiety disorders, personality disorders and attention-deficit/
hyperactivity disorder (ADHD) (NICE 2014b). Furthermore, the risk of suicide among 
those with bipolar disorder is approximately 20–30 times greater than that in the 
general population (Pompili et al. 2013). It has a peak age of onset between 15–19 
years, though it is recognised that there is often considerable delay between onset 
and treatment, with those seeking help not receiving a correct diagnosis for around 
six years from the onset of symptoms and very often longer (NICE 2015). Diagnosis 
of bipolar disorder is challenging, in that it cannot be confidently differentiated 
from unipolar depression until an episode of hypomania is identified. Further, the 
prevalence of depressive symptoms in people with bipolar is greater than that of 
elated mood (Philips and Kupfer 2013).
Treatment options, as based on the guidelines of the National Institute for 
Health and Care Excellence (NICE), vary depending on whether the individual is 
experiencing a depressive or manic (hypomanic) episode. For manic or hypomanic 
episodes, treatment will usually involve some form of mood stabilising medication, 
which can take the form of anti-psychotic drugs. For depressive episodes NICE 
currently recommends psychological therapies such as cognitive behavioural therapy 
(CBT), and/or medication. Long term treatment with mood stabilising medication 
such as lithium is also recommended as maintenance treatment to reduce the risk 
of relapse (NICE 2014a). NICE estimates that 25% of adults with bipolar disorder 
never seek help or treatment (2014b).
9.2 Definition and assessment
Bipolar disorder
There are a number of subtypes of bipolar disorder recognised in the new edition 
of the US-based Diagnostic and Statistical Manual of Mental Disorders (DSM-5) with 
the major groupings being: bipolar I; bipolar II and cyclothymia (APA 2013). In the 
WHO’s International Classification of Diseases version 10 (ICD-10), no distinction is 
made between type I and II.
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Bipolar I disorder is characterised by at least one lifetime episode of mania; 
a period of elevated mood and increased levels of energy including such 
symptoms as increased talkativeness, inflated self-esteem, feelings of grandiosity, 
and a decreased need for sleep, that lasts at least one week and causes significant 
impairment in social or occupational functioning. Whilst in DSM-5 a manic 
episode is sufficient to make the diagnosis of bipolar I, in ICD-10 the experience 
of a depressive episode is required for the bipolar disorder diagnosis to be made. 
The vast majority of people experiencing a manic episode will however go on 
to develop a depressive episode in their lifetime (Phillips and Kupfer 2013). 
Diagnosis for bipolar II disorder requires at least one episode of hypomania, similar 
to a manic episode though not severe enough to cause impairment in social or 
occupational functioning, and at least one episode of major depression. 
For a diagnosis of cyclothymia, the individual must experience hypomanic and 
depressive symptoms that fall short of the criteria for a manic, hypomanic or major 
depressive episode. DSM-5 also identifies ‘other specified bipolar and related 
disorders’ (previously referred to as ‘bipolar not otherwise specified (NOS)’ by DSM-IV) 
for instances in which there is significant distress or impairment but not meeting the 
full diagnostic criteria for previously defined bipolar disorder subtypes (APA 2000). 
Mood Disorder Questionnaire (MDQ)
Bipolar disorder was assessed in the APMS 2014 self-completion using the 
Mood Disorder Questionnaire (MDQ), a self-report 15-item scale based on DSM-IV 
criteria (the diagnostic classification system current at the time the survey was in 
development). It was designed to screen for bipolar spectrum disorders, i.e. bipolar I, 
bipolar II, cyclothymia and bipolar NOS. This assesses lifetime experience of manic 
or hypomanic symptoms by way of 13 yes/no items. It also establishes whether 
several of the symptoms have been experienced at the same time, and whether 
they have caused moderate to serious problems (Hirschfield et al. 2000).
A positive screen for bipolar disorder requires endorsement of at least 7 lifetime 
manic/hypomanic symptoms, as well as several co-occurring symptoms, and 
moderate or serious associated functional impairment. 
The MDQ has been used in a number of large scale epidemiological studies in 
the US. It was developed and validated using a psychiatric outpatient population, 
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and was found to correctly identify seven out of 10 people with bipolar disorder, 
and successfully screen out nine out of 10 people that did not have bipolar disorder 
(APA 2013). A general population study showed similarly specificity rates, though 
limitations were noted since the sensitivity (the ability to identify those with 
bipolar disorder successfully) was low (0.28) (Hirschfield et al. 2003). 
All participants in APMS 2014 were asked the first 13 items on the MDQ. Those 
who answered ‘yes’ to at least seven of these items were asked whether they had 
experienced several symptoms at the same time, and if so, how much of a problem 
this caused in terms of being unable to work; having family, money or legal 
troubles; or getting into arguments or fights.
Mood Disorder Questionnaire
Has there ever been a period of time when you were not your usual self and…  Yes/No
… you felt so good or so hyper that other people thought you were not your 
normal self or you were so hyper that you got into trouble?
… you were so irritable that you shouted at people or started fights or arguments? 
… you felt much more self-confident than usual? 
… you got much less sleep than usual and found you didn’t really miss it?
… you were much more talkative or spoke much faster than usual?
… thoughts raced through your head or you couldn’t slow your mind down? 
… you were so easily distracted by things around you that you had trouble 
concentrating or staying on track?
… you had much more energy than usual? 
… you were much more interested in sex than usual? 
… you were much more active or did many more things than usual? 
… you were much more social or outgoing than usual, for example, you 
telephoned friends in the middle of the night?
… you did things that were unusual for you or that other people might have 
thought were excessive, foolish, or risky?
… spending money got you or your family into trouble?
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Note that the term ‘screening’ is used here to refer to identifying people with 
a high likelihood of having a disorder. A definitive diagnosis of bipolar disorder 
would require a comprehensive clinical assessment which was not carried out in 
this survey. The MDQ is not used as part of any National Screening Programme 
in England. 
9.3 Results 
Screening positive for bipolar disorder, by age and sex 
Overall, 2.0% of participants screened positive for bipolar disorder, with the rate in 
the wider population likely to be (with 95% confidence) between 1.6% and 2.4%. 
There was no significant difference in the rates for men and women (2.1% for men 
and 1.8% for women). However, the proportion screening positive for bipolar 
disorder did vary by age, being more common in younger age-groups: 3.4% of 
16–24 year-olds screened positive compared with 0.4% of those aged 65–74. None 
of the participants aged 75 and over screened positive for bipolar disorder. Table 9.1
Figure 9A: Positive bipolar disorder screen, by age and sex  
Base: all adults
%
Men Women
Positive bipolar disorder screen
16–24 25–34 35–44 45–54 55–64 65–74 75+
0
0.5
1
1.5
2
2.5
3
3.5
4
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Variation in screening positive for bipolar disorder by other characteristics 
Ethnic group
Screening positive for bipolar disorder did not vary by ethnic group. This was the 
case whether or not the analysis was age-standardised. Table 9.2
Household type
Bipolar disorder screen positive rates varied with the type of household people 
lived in. Among people aged less than 60, 5.5% living in a household as a lone 
occupant screened positive for bipolar disorder, compared with 1.9% who lived 
with one other person. Rates for other types of household ranged between 
0.4% and 2.6%. Table 9.3
Figure 9B: Positive bipolar disorder screen, by household type and sex
Base: all adults
Men Women
%
1 adult 
16–59, 
no child
2 adults 
16–59, 
no child
Small family Large family Large adult 
household
2 adults 
one or both 60+, 
no child
1 adult 60+, 
no child
Household type
0
1
2
3
4
5
6
7
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Region
The proportion screening positive for bipolar disorder did not differ by region. 
Table 9.4
Employment status 
The likelihood of screening positive for bipolar disorder varied with employment 
status. 16 to 64 year olds who were either unemployed or economically inactive 
were more likely to screen positive (3.9% and 4.3% respectively, age-standardised), 
while their counterparts in employment (1.9%) were less likely to. In men, the 
highest rates were observed in the economically inactive and in women the highest 
rates were observed in the unemployed, although this variation was not significant. 
Table 9.5
Figure 9C: Positive bipolar disorder screen, by employment status and sex
Base: all adults aged 16–64
Men Women
%
0
1
2
3
4
5
6
Employed Unemployed Economically inactive
Employment status
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Benefit status 
Benefit status was looked at in relation to three groupings: being in receipt of any 
out-of-work benefit (including Jobseeker’s Allowance and Employment and Support 
Allowance (ESA)), receiving an out-of-work benefit specifically related to disability 
(ESA), and living in a household that received housing benefit support with rent. 
These categories are further described in the Glossary.
Screening positive for bipolar disorder was significantly more likely in people who 
received any form of benefit than in those who did not. The strongest association 
was observed for those who received an out-of-work benefit related to disability 
(ESA); 12.4% screened positive compared with 2.0% who did not receive the 
benefit. Moreover, among those receiving this type of benefit, women were almost 
four times more likely to screen positive for bipolar disorder (21.4%) than men 
(5.7%). Table 9.6
Figure 9D: Positive bipolar disorder screen, by receipt of Employment 
and Support Allowance and sex
Base: all adults aged 16–64
Men Women
%
0
5
10
15
20
25
Yes No
Out-of-work benefit related to disability (ESA) 
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Self-diagnosis and professional diagnosis of bipolar disorder
Participants were asked whether they themselves thought they had ever 
experienced bipolar disorder. If they did, they were asked whether this had been 
diagnosed by a professional, and if they thought that the disorder had been present 
in the last 12 months. 
80 people in the APMS survey sample (1.0%) reported thinking they had had 
‘bipolar disorder or manic depression’ at some point. Most of these participants 
(62) had this diagnosis confirmed by a professional, and for more than half 
(48 participants) the condition was felt to be present in the last 12 months. 
Of people who had had bipolar disorder diagnosed by a professional and for whom 
this had been present in the past 12 months, 38.3% screened positive on the MDQ. 
No differences were found between men and women. Table 9.7
Treatment and service use
Participants were asked about a range of types of mental health treatment and 
service use. These included current medication or psychological therapy for a mental 
or emotional problem, together with the use of a range of health, community and 
day care services over the last year. 
Of those who screened positive for bipolar disorder, 6 out of 10 were not in receipt 
of any current medication or treatment (59.9%). Those who screened positive were, 
nonetheless, considerably more likely to report receiving some form of psychotropic 
medication (37.8%) or psychological therapy (16.4%) than those who screened 
negative (9.6% and 2.6% respectively). 
Those who screened positive were also more likely to report using the other 
types of service asked about. For example, half of those screening positive for 
bipolar disorder reported having used a health care service in the past year (50.0%), 
compared with a tenth of those who screened negative (11.8%). Table 9.8
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Regarding the type of medication received by people screening positive for bipolar 
disorder, the most common medications were those used to treat anxiety (30.0%) 
or depression (29.6%), followed by 14.5% who took medication specifically for 
bipolar disorder. For all types of psychotropic medication, with the exception of 
medication used to treat ADHD, those screening positive were more likely to be 
taking it than those screening negative. Table 9.9
Participants were asked if they had requested a particular treatment in the past 
12 months but had not received it. One in eight people who screened positive 
for bipolar disorder reported requesting but not receiving some form of mental 
health treatment (12.7%), this compared with 1.4% of bipolar screen negatives. 
Table 9.10
Figure 9E: Current treatment for a mental or emotional problem, 
by bipolar disorder screen
Base: all adults
Bipolar disorder screen positive Bipolar disorder screen negative
No treatment Medication only Both medication 
and counselling
Counselling 
or therapy only
0
10
40
30
20
60
50
70
90
80
100%
Current treatment for a mental or emotional problem
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9.4 Discussion
This chapter presents findings on bipolar disorder, a newly-introduced module 
within APMS 2014, to provide much-needed information on prevalence and 
sociodemographic profile of people with bipolar disorder in England. The overall 
prevalence of likely bipolar disorder in the APMS 2014 was 2.0%, closely consistent 
with findings from epidemiological studies in other countries (Merikangas et al. 
2011; Merikangas et al. 2007). Rates were similar for men and women and higher 
in younger than older people. 
Prior to these findings, no lifetime prevalence rates from a UK general 
population survey were available for bipolar disorder (Pini et al. 2005). Based on 
studies conducted in other countries, however, prevalence rates worldwide have 
been conservatively estimated at between 1–1.5% (Bebbington and Ramana 
1995), and as high as 5% (Akiskal et al. 2000) in relation to the full spectrum of 
bipolar disorder. The World Mental Health Survey Initiative reported that the lifetime 
aggregate prevalence from 11 countries (not UK) was 2.4% for bipolar disorders 
(BP-I, BP-II, and subthreshold BP) (Merikangas et al. 2011). The APMS 2014 data 
are consistent with this range. 
It is important to note however, that the instrument used for screening for 
bipolar disorder while designed to screen for the full bipolar spectrum disorders 
does have limitations. The MDQ is less sensitive at identifying bipolar II disorders 
than the longer Hypomania Checklist, another widely used instrument (Meyer et 
al. 2011). There are also limitations on its use in general population studies (APA 
2000). Whilst showing excellent specificity (suggesting a positive result is useful for 
ruling in bipolar disorder) the instrument has been shown to have limited sensitivity 
(the proportion of people with a condition who have a positive result); thus these 
survey prevalence rates may be underestimates.1 Overall the MDQ, albeit limited by 
these considerations, appears to have performed reasonably well in the APMS 2014. 
Bipolar disorder is known to cause considerable disability, together with 
impairments in work and social life (Sanchez-Moreno et al. 2009), and this 
1 For discussion of specificity and sensitivity see: Centre for Evidence-based Medicine: www.cebm.net/sppin-and-snnout/
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is reflected in the findings presented in this chapter. There was a revealing 
relationship with household type. People living alone were more likely to screen 
positive than those living with other people, consistent with evidence suggesting 
links between bipolar disorder, social isolation and difficulty with relationships. 
Individuals who were unemployed or economically inactive were also more likely to 
screen positive for bipolar disorder. This parallels the increased proportion of people 
screening positive for bipolar disorders among those receiving some form of out of 
work benefit, or housing benefit. Examination of the data by ethnicity and region 
showed no associations, although the sample size is small for such comparisons.
The age distribution replicated US data for bipolar disorder and indeed was similar 
to the distribution for several other mental disorders (Kessler et al. 2005). However, 
as bipolar disorder is a lifelong condition, we would have expected the prevalence 
to gradually increase with age. The survey findings may represent a problem of 
recall. The increased mortality associated with the disorder may also be part of 
the explanation.
NICE estimate a possible delay of 6 years between the onset of symptoms and 
treatment, while around 25% of affected adults never seek treatment for bipolar 
disorder (NICE 2014b). The APMS data presented here shows that around a third 
of people screening positive for bipolar disorder believed that they have had the 
disorder, and of those, a third had been diagnosed by a professional. 
The majority of people screening positive for bipolar disorder were not currently 
receiving any form of treatment, either psychological therapy or psychotropic 
(mental health) medication. Furthermore, one in eight who screened positive for 
bipolar disorder had asked for, but not received, some particular form of mental 
health treatment in the last 12 months. 
Almost 40% of adults screening positive for bipolar disorder were currently 
taking some form of psychotropic medication, with 14% prescribed this in 
combination with some form of psychological therapy. Only a small percentage 
was receiving psychological therapy only. Recommendations for treatment vary, 
depending on whether the individual is experiencing a manic (hypomanic) episode 
or a depressive episode. Manic episodes are usually treated pharmacologically 
with antipsychotics, whereas depressive episodes are treated either psychologically 
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or with medication (NICE 2015b). Almost a third of people screening positive for 
bipolar disorder reported taking medications indicated for anxiety, consistent with 
the high prevalence of comorbid anxiety disorder in bipolar disorder reported in 
previous studies. The second most prevalent medication was that primarily indicated 
for depression, and again this is consistent with the prevalence of depressive 
symptoms being higher in people with bipolar disorder than manic or hypomanic 
symptoms (Pompili et al. 2013). 
Some of the comparisons reported in this chapter are based on small numbers and 
must be interpreted with caution. In addition, due to the cross-sectional nature of 
these data, the direction of cause and effect is unclear. 
The findings discussed in this chapter were consistent with prevalence studies 
internationally, despite the limitations of the survey assessment method. They 
offer much needed information on the characteristics, difficulties and health 
service contact of people with bipolar disorder living in the community. Future 
study is warranted to establish the prevalence of bipolar subtypes, why people 
do not seek or obtain help, and how health services might adapt to better 
meet the needs of the whole population of people with bipolar disorder. 
9.5 Tables
Prevalence and trends 
Table 9.1  Number of bipolar disorder characteristics reported (lifetime), 
by age and sex 
Characteristics  
Table 9.2  Screen positive for bipolar disorder (observed and age-standardised), 
by ethnic group and sex 
Table 9.3  Screen positive for bipolar disorder, by household type and sex 
Table 9.4  Screen positive for bipolar disorder (observed and age-standardised), 
by region and sex 
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Table 9.5  Screen positive for bipolar disorder (age-standardised), 
by employment status and sex 
Table 9.6  Screen positive for bipolar disorder (age-standardised), 
by benefit status and sex
Treatment and service use 
Table 9.7  Screen positive for bipolar disorder, self-diagnosis and professional 
diagnosis of bipolar disorder
Table 9.8  Treatment and service use, by bipolar disorder screen 
Table 9.9  Psychotropic medication taken, by bipolar disorder screen
Table 9.10  Requested but not received a particular mental health treatment 
in the past 12 months, by bipolar disorder screen
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